Vaccines List

ACI-35.030 is a first-in-class vaccine candidate designed to generate a specific antibody response against pTau proteins in the brain.Read more...

Ad26.Mos4.HIV is a tetravalent vaccine candidate containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts.Read more...

Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola virus disease.Read more...

AdCOVID COVID-19 vaccine candidate is based on Altimmune Inc.'s adenovirus-based intranasal vaccine platform and expresses the receptor-binding domain of the SARS-CoV-2 spike protein.Read more...

AG0301 COVID-19 Vaccine candidate is a plasmid DNA vaccine that disables the connection between the protein spikes of the coronavirus and receptors in human cells.Read more...

AV7909 is a combination of BioThrax (also called anthrax vaccine, adsorbed or AVA), an FDA-licensed vaccine, and CPG 7909.Read more...

Bacille Calmette-Guerin (BCG) vaccine is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis.Read more...

BBV154 is an intranasal vaccine that stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.Read more...

Bexsero contains different proteins taken from group B Neisseria meningitidis bacteria. The combination of proteins was chosen to protect against the majority of MenB strains. They are also expected to protect against other types of meningococcal bacteria, including MenW.Read more...

BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...

Boostrix vaccine is used to help prevent tetanus, diphtheria, and pertussis in people who are at least 10 years old. Most people in this age group require only one Tdap shot for protection against these diseases.Read more...

Brilacidin is a synthetic, non-peptidic small molecule that kills pathogens swiftly, significantly reducing the likelihood of drug resistance developing. Brilacidin also functions in a robust immunomodulatory capacity, lessening inflammation, and promoting healing.Read more...

BVRS-GamVac-Combi MERS Vaccine candidate is intended to prevent Middle East Respiratory SyndromeRead more...

Cervarix vaccine is a non-infectious recombinant, AS04-adjuvanted vaccine, that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. Read more...

ChiroRab is an inactivated rabies virus of the strain Flury LEP, produced in India.Read more...

CoraVax utilizes the spike protein component of the SARS-CoV-2 virus.Read more...

CoronaVac (Sinovac COVID-19 vaccine) is based on an inactivated pathogen produced by Sinovac Biotech Life Sciences, Beijing, ChinaRead more...

CoVepiT is a prophylactic vaccine candidate against COVID-19 based on optimized peptides selected to induce a lasting sentinel T lymphocyte immune response against SARS-CoV-2 in barrier tissues such as the respiratory tract and the lung.Read more...

COVID-19 Long-Acting Antibody (AZD7442) has been engineered with AstraZeneca’s proprietary half-life extension technology to increase the durability of the therapy for six to 12 months following a single administration.Read more...

The COVID-19 Vaccine Moderna Intramuscular Injection is an mRNA vaccine targeted against the SARS-CoV-2 coronavirus encoding for a prefusion stabilized form of the Spike (S) protein authorized for use in Japan on May 21, 2021.Read more...

CoviShield is the Serum Institute of India version of the AstraZeneca COVID-19 vaccine.Read more...

Medicago CoVLP SARS-CoV-2 vaccine candidate uses living plants as bioreactors to produce non-infectious versions of viruses Read more...

CTH522 is a Chlamydia vaccine candidate adjuvanted with CAF01 liposomes or aluminium hydroxide.Read more...

CureVac CVnCoV mRNA vaccine candidate utilizes nucleotides without chemical modifications.Read more...

Delta gD-2 (∆gD-2) Herpes Vaccine candidate elicits antibodies that facilitate the killing of infected cells, which then rapidly clears the HSV-1 and HSV-2 viruses.Read more...

Diamyd® is an antigen-specific immunotherapy for the preservation of endogenous insulin production. Read more...

Ebola vaccines include replication-deficient adenovirus vectors, replication-competent vesicular stomatitis, human parainfluenza (HPIV-3) vectors, and virus-like nanoparticle preparations.Read more...

Engerix-B a Hepatitis B Vaccine is a noninfectious recombinant DNA hepatitis B vaccine.Read more...

The EpiVacCorona peptide antigens-based vaccine contains fragments extracted from the virus that initiates immune reactions against COVID-19. Read more...

Eupolio Polio Vaccine is a Sabin-Inactivated Polio Vaccine (Sabin-IPV).Read more...

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza.Read more...

Fluarix Quadrivalent is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.Read more...

Flucelvax Quadrivalent (QIVc) is a cell culture-based flu vaccine to help offer protection against 4 flu virus strains identified for the current flu season.Read more...

FluMist Quadrivalent is an Intranasal vaccine that is a live quadrivalent vaccine that is formulated to contain four vaccine virus strains.Read more...

Gardasil vaccine consists of 4 proteins of HPV types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...

GEN-003 is an experimental immunotherapy vaccine comprised of 2 HSV-2 proteins, glycoprotein D2 and ICP4.2, and Matrix-M2 adjuvant (M2).Read more...

GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinatedRead more...

Havrix is a sterile suspension of inactivated virus strain HM175 which is propagated in MRC-5 human diploid cells.Read more...

HBAI20 vaccine candidate consists of a standard HBV vaccine to which the AI20 adjuvant is added. The adjuvant is able to give an additional stimulus to the immune system and may provide sufficient protection against HBV for the non-responders.Read more...

Hepatitis vaccines treat inflammation of the liver. There are 5 main hepatitis viruses, referred to as types A, B, C, D and E.Read more...

HER-Vaxx (IMU-131) is a B-cell peptide immunotherapy cancer vaccine candidate which is constructed from several B cell epitopes derived from the extracellular domain of HER-2/neu. Read more...

HGCO19 COVID-19 Vaccine is India's first indigenous messenger RNA (mRNA) vaccine.Read more...

The herpes simplex virus type 2 (HSV-2) vaccine candidate (GSK4108771A) utilizes self-amplifying messenger RNA, "SAM" technology. Read more...

HydroVax-001 is a vaccine candidate that consists of a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) adjuvanted with aluminum hydroxide.Read more...

Imovax Rabies is an inactivated vaccine made from an attenuated rabies virus. It is a sterile, stable, freeze-dried suspension of Rabies Vaccine Inactivated virus prepared from WISTAR Rabies PM/WI 38 1503-3M strain.Read more...

Influenza vaccines, known as flu shots, protect people against the influenza viruses that research indicates will be most common during the upcoming season. Read more...

INO-3107 is a DNA medicine being evaluated for the treatment of recurrent respiratory papillomatosis.Read more...

INO-4700 is a DNA plasmid vaccine candidate that expresses the MERS CoV spike (S) glycoprotein.Read more...

INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) technology candidate.Read more...

Ixiaro is an inactivated, adsorbed Vero cell culture-derived preventive vaccine against the Japanese encephalitis virus and is prepared by propagating JEV strain SA14-14-2 in Vero cells.Read more...

JENVAC is an inactivated vero cell-derived vaccine prepared from an Indian Kolar strain of the Japanese encephalitis virus.Read more...

Kinrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) is a noninfectious, sterile vaccine for intramuscular administrationRead more...

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

Pfizer’s pentavalent meningococcal vaccine candidate (PF-06886992) combines its two approved meningococcal vaccines, Nimenrix™ (meningococcal group A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).Read more...

Meningococcal vaccines prevent illness caused by bacteria called Neisseria meningitidis, also known as meningococcus. These illnesses are often severe and can be deadly.Read more...

MK-7110 (CD24Fc) COVID-19 Therapeutic candidate is a first-in-class recombinant fusion protein that targets the innate immune system.Read more...

Molnupiravir (MK-4482, EIDD-2801) is an investigational, orally bioavailable form of a potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19.Read more...

mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine candidate encodes for a prefusion F glycoprotein, which elicits a superior neutralizing antibody response.Read more...

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

Moderna's mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

Translate Bio and Sanofi MRT5500 is an mRNA SARS-CoV-2 vaccine candidateRead more...

MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...

MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...

NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...

NEO-PV-01  Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...

nOPV2 Polio Vaccine candidate is derived from the live, infectious virus — but this time it has been ‘triple-locked’ using genetic engineering, to prevent it from becoming harmfulRead more...

Olumiant (Baricitinib) is a Janus kinase inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation.Read more...

Pediarix is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, and infection caused by all known subtypes of hepatitis B virus and poliomyelitis. Pediarix is a three-dose series.Read more...

PennVax-GP has been optimized to target two env antigens, as well as gag and pol antigens. This comprehensive targeting gives PennVax-GP the potential to provide global coverage against HIV-1 subtypesRead more...

PF-07321332 is an oral antiviral therapeutic targeting the SARS-CoV-2 virus.  PF-07321332 is a protease inhibitor that has demonstrated potent in vitro anti-viral activityRead more...

Plaquenil (hydroxychloroquine) is used to prevent or treat malaria, and for certain rheumatoid arthritis, systemic lupus erythematosus, and porphyria cutanea trade therapies.Read more...

Pneumosil is indicated against invasive disease, pneumonia, and acute otitis media caused by 10 Streptococcus pneumoniae serotypes in infants and toddlers from 6 weeks up to 2 years of age.Read more...

Prevnar 13 is a vaccine that is approved for the prevention of pneumococcal pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. Read more...

Priorix is a vaccine to protect against measles, mumps, and rubella. Priorix is currently licensed outside the USA in over 100 countries. Priorix-TETRA includes protection for measles, mumps, rubella, and varicella.Read more...

Quadracel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis.Read more...

RabAvert is a vaccine that contains an inactivated rabies antigen.Read more...

RAPIVAB (peramivir injection) is an influenza virus neuraminidase inhibitor.Read more...

Redeeflu is a nasal vaccine candidate utilizing a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate. The F protein is essential to RSV infectivity and is the target of palivizumab.Read more...

RiVax Ricin Toxin Vaccine is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin.Read more...

RotaTeq is a live, oral vaccine that helps prevent rotavirus infection in children.Read more...

RV144 is an HIV vaccine candidate that combines two different vaccine types: a prime and a booster.Read more...

The Sanofi - GSK vaccine candidate combines innovative technologies to produce an adjuvanted recombinant protein-based COVID-19 vaccine.Read more...

SCIB1 is a cancer vaccine candidate that is being developed for the treatment of melanoma.Read more...

Sinopharm BBIBP-CorV COVID-19 is an inactivated vaccine that is made of virus particles that are grown in culture and lack disease-producing capability.Read more...

Sky Zoster is a live-attenuated zoster vaccine developed and tested in Korea Read more...

SpFN SARS-CoV-2 vaccine attaches a certain type of spike protein to the polymerized version of ferritin to prevent COVID-19 diseaseRead more...

The Russian Sputnik V vaccine (Gam-COVID-Vac) uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.Read more...

SurVaxM is a peptide mimic immunotherapeutic vaccine (immunotherapy) that targets survivin, a cell-survival protein present in 95 percent of glioblastomas and many other cancers.Read more...

TAK-214 a vaccine candidate uses virus-like particle (VLP) antigens, which are proteins that precisely mimic the outer surface of norovirus. The vaccine includes antigens from genotypes GI.1 and GII.4, to represent both of the genogroups that cause the majority of human illness.Read more...

TetraVax-DV-TV003 is a live attenuated recombinant tetravalent dengue vaccine.Read more...

TG4050 is an individualized therapeutic vaccine designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...

UK marketing authorization was granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2Read more...

Twinrix is a bivalent vaccine that is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. Read more...

Typbar TCV is the world’s first clinically proven conjugate Typhoid vaccine.Read more...

The UB-612 Vaxxinity vaccine is designed to target a critical antigen from the S protein (Receptor Binding Domain, RBD) thought to be necessary for viral attachment to human cells plus additional viral epitopes (from other viral structural proteins) designed to promote B-cell and CD8+ T-cell memory responses. Read more...

Merck V114 vaccine consists of pneumococcal polysaccharides from 15 serotypes conjugated to a CRM197 carrier protein and includes serotypes 22F and 33F, which are commonly associated with invasive pneumococcal disease worldwide.Read more...

V591 SARS-CoV-2 vaccine candidate uses a measles virus vector platform to deliver the antigens to the immune system to spur antibody production against SARS-CoV-2Read more...

Varivax is a live, attenuated varicella-zoster vaccine, a weakened form of the chickenpox virus.Read more...

Vaxchora is a live attenuated recombinant oral V. cholerae O1 Inaba Vaccine Strain CVD 103-HgR, which is able to synthesize the immunogenic nontoxic B subunit of CT (encoded by the ctxB gene).Read more...

Vaxzevria COVID-19 Vaccine (AstraZeneca) (AZD1222) (ChAdOx1 nCov-19) (C19VAZ) (CovidShield) consists of the replication-deficient simian adenovirus vector ChAdOx1, containing the genetic sequence of the SARS-CoV-2 Spike protein.Read more...

VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma, two types of brain tumors.Read more...

VC2 vaccine candidate is a live-attenuated, engineered version of HSV-1. The VC2 vaccine targets facial, ocular, and genital herpes caused by HSV-1 but may also protect against genital herpes caused by HSV-2. Read more...

VGX-3100 is an investigational immunotherapy vaccine that includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16 and 18.Read more...

Vitagerpavac is a multivalent vaccine in the world for the treatment of chronic herpesvirus infection (HCV) of types I and IIRead more...

Lyme Disease vaccine candidate VLA15 targets the outer surface protein A (OspA) of Borrelia. It is designed for prophylactic, active immunization against Lyme disease aiming for protection against the majority of human pathogenic Borrelia species.Read more...

VLA1601 is a purified, inactivated, whole Zika virus vaccine candidate adsorbed on aluminum hydroxide (alum).Read more...

VTP-500 (ChAdOx1) MERS vaccine candidate treats MERS-CoV coronavirus utilizing the ChAdOx1 virus platform to encode MERS coronavirus spike protein in order to induce T cellsRead more...

YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...

ZF2001 is a protein subunit vaccine using a dimeric form of the receptor-binding domain (RBD) as the antigen, a harmless piece of the SARS-Cov-2 virus. Read more...

ZyCoV-D is a DNA vaccine candidate to fight COVID-19 disease.Read more...